Mona Ahmed Mohamed
Lecturer
Significance of sex-determining region Y box family members (SOX6 and SOX9) in clear cell renal cell carcinoma: immunohistochemical study
• 2024
Publication Information
Authors
Eman A. Saad, Rana M. Abdalla, Mona A. Aboelkheir
Keywords
Not Available
Journal
Not Available
Publisher
Not Available
Volume
Not Available
Issue
Not Available
Pages
Not Available
publication.type
Local
Paper Link
Not Available
Supplementary Materials
Not Available
Abstract
Background
Renal cell carcinoma (RCC) ranks as the third most common urological
malignancy worldwide, comprising ~2.2% of all cancers. The clear cell subtype,
which accounts for 80–90% of RCC cases, is characterized by a wide spectrum
of survival outcomes. The sex-determining region Y box (SOX) family of
proteins, expressed in multiple cell types, plays a crucial role in regulating cell
differentiation and fate in various physiological contexts. Among them, SOX6
and SOX9 have been implicated in the regulation of carcinogenesis in several
human cancers.
Aim
The primary objective of this study is to investigate the immunohistochemical
expression of SOX6 and SOX9 in clear cell RCC, with a focus on their potential
role in tumor progression and as predictors of patient prognosis and survival.
This retrospective analysis included 50 cases of clear cell RCC. Immunostaining
for SOX6 and SOX9 was performed, and the results were correlated with
clinicopathological features.
Results
SOX6 and SOX9 expression was significantly altered in RCC compared with normal
renal tissue (P
Renal cell carcinoma (RCC) ranks as the third most common urological
malignancy worldwide, comprising ~2.2% of all cancers. The clear cell subtype,
which accounts for 80–90% of RCC cases, is characterized by a wide spectrum
of survival outcomes. The sex-determining region Y box (SOX) family of
proteins, expressed in multiple cell types, plays a crucial role in regulating cell
differentiation and fate in various physiological contexts. Among them, SOX6
and SOX9 have been implicated in the regulation of carcinogenesis in several
human cancers.
Aim
The primary objective of this study is to investigate the immunohistochemical
expression of SOX6 and SOX9 in clear cell RCC, with a focus on their potential
role in tumor progression and as predictors of patient prognosis and survival.
This retrospective analysis included 50 cases of clear cell RCC. Immunostaining
for SOX6 and SOX9 was performed, and the results were correlated with
clinicopathological features.
Results
SOX6 and SOX9 expression was significantly altered in RCC compared with normal
renal tissue (P